Novartis unveils positive study data on Zolgensma gene therapy
The SMART study is reportedly the first open-label clinical trial of Zolgensma to include previously treated patients.
KEYSTONE
Novartis has presented new study data on Zolgensma, its gene therapy treating spinal muscular atrophy (SMA). The data once again underscored the efficacy of this single-dose gene therapy in patients with SMA, according to a press release issued on Monday.
This content was published on
2 minutes
Keystone-SDA
العربية
ar
نوفارتيس السّويسريّة تكشف عن نتائج إيجابيّة لدراسة حول علاج زولجنسما الجّينيّ
The results of the SMART study added to what is known about the use of Zolgensma in patients who are older (1.5 – 9.1 years) and suffer more severely than the children treated in previous clinical trials.
In almost all cases, the motoric milestones of treated patients were maintained or even improved after 52 weeks. Many of these patients had switched therapies, having previously been treated with a different disease-modifying agent.
More
More
Swiss trade deal: Is India changing its tune on pharma patents?
This content was published on
Patent protection for the Swiss pharmaceutical industry has been a key sticking point in a free trade deal with India. What’s changed?
The SMART study is reportedly the first open-label clinical trial of Zolgensma to include previously treated patients. Novartis announced that it will present the data at the Muscular Dystrophy Association (MDA) conference, which is taking place in the US until March 6.
Adapted from German by DeepL/dkk/amav
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
This content was published on
The Fribourg parliament approved a sum of CHF6.4 million to renovate the ramparts, the walkway and the towers, as well as to replace the exterior lighting.
Swiss rental housing listings increase for the first time in three years
This content was published on
For the first time in three years, the number of advertisements for rental accommodation is on the rise, but this does not dampen demand, quite the contrary. In Ticino, the average duration of an advertisement published on the main portals is 30 days.
Switzerland doing relatively well when it comes to child vaccination rates
This content was published on
Progress in child immunisation has stalled. For decades, the number of children vaccinated against measles, polio and other diseases has risen. But since 2010, vaccination rates have stagnated in many countries, according to a study.
This content was published on
Human remains were found and recovered on Tuesday as part of a search operation in the buried Valais mountain village of Blatten. Formal identification is underway, according to the Valais cantonal police.
Switzerland and the EU sign declaration on transitional arrangements
This content was published on
They set out the terms of cooperation for the period until the desired entry into force of the package of bilateral agreements.
Swiss price watchdog negotiates lower fees for card payments
This content was published on
Small businesses in Switzerland will have to pay fewer fees for cashless payments from customers over the next few years.
Lakes in Central Switzerland have best water quality for bathing
This content was published on
Anyone who swims in a lake in Central Switzerland need have no fear of infection from intestinal bacteria. The water samples taken at 65 bathing sites in 13 lakes all have good to excellent bathing water quality.
This content was published on
Unknown assailants have stolen a historic ring from a Basel museum. The stolen item was a gift from Russian Tsar Alexander I to his host in Basel in 1814.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss trade deal: Is India changing its tune on pharma patents?
This content was published on
Patent protection for the Swiss pharmaceutical industry has been a key sticking point in a free trade deal with India. What’s changed?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.